Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
Clinical, Radiographic and Histological Evaluation of the Efficacy of Oxygen-Releasing Oral Gel in Enhancing Tissue Healing Following Extraction :A Randomized Comparative Study
研究概览
详细说明
Wound healing presents significant clinical challenges, particularly among immunocompromised individuals and patients suffering from chronic systemic conditions such as diabetes. These patient groups are more prone to postoperative complications and frequently experience delayed healing processes. Under normal physiological conditions, wound healing follows a cascade that heavily depends on the formation of granulation tissue, where blood vessels play a crucial role. As the healing tissue matures, the density of these vessels diminishes. However, in diabetic individuals, impaired immune responses and defective neovascularization significantly hinder this process. Interestingly, the oral mucosa demonstrates a unique healing pattern-characterized by a reduced vascular response yet more mature and efficient capillaries. This feature promotes enhanced oxygen delivery to regenerating tissues and contributes to faster healing. A key factor impeding effective wound healing is insufficient tissue oxygenation, often caused by compromised vascular supply. This deficiency adversely affects leukocyte-mediated bacterial clearance and tissue regeneration. Oxygen is vital not only for cellular repair mechanisms but also for its antimicrobial effects, particularly through oxidative microbial destruction.
研究类型
注册 (实际的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Egypt
-
Ismailia、Egypt、埃及
- Faculty of dentistry Suez canal university
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
-
Age ≥ 18 years (able to sign informed consent).
-
Requires extraction of at least one hopeless tooth meeting one or more of the following:
- Furcation involvement > Class II -Tooth mobility > Grade II
- Probing pocket depth (PPD) > 6 mm
- Alveolar bone loss ≥ 70% of root length
- Persistent radiographic pathology or chronic symptoms (e.g., pain, fistula, infection)
- Non-restorable condition
-
The case can be prepared for implant placement
Exclusion Criteria:
- General contraindications to surgery
- Pregnancy or breastfeeding
- Uncontrolled diabetes
- Current or previous intravenous bisphosphonate therapy
- History of allergic reaction to the applied gel or any of its components
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Study with BlueM gel
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
|
安慰剂比较:Control without BlueM gel
Standard postoperative care without the use of the gel, allowing for natural healing. |
BlueM oxygen releasing oral gel will be applied topically on the extraction site immediately after the procedure standard postoperative care without the use of the gel, allowing for natural healing |
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Post-operative pain
大体时间:1, 3 and 7 days
|
Post-operative pain levels assessed using the Visual Analog Scale (VAS), where higher scores indicate worse outcomes (more pain). Minimum score = 0 (No pain); Maximum score = 10 (Severe pain that completely prevents daily activities). |
1, 3 and 7 days
|
|
post-operative complications
大体时间:1, 3 and 7 days
|
Measure the incidence of post-operative complications (e.g., dry socket, infection) in both groups. |
1, 3 and 7 days
|
|
Clinical signs of inflammation
大体时间:1, 3 and 7 days
|
Clinical signs of inflammation assessed using an ordinal clinical grading scale for swelling, where higher scores indicate worse outcomes (more severe inflammation). Scale ranges from 1 to 4: 1 = none (no visible swelling), 2 = mild (intraoral swelling in the surgical zone), 3 = moderate (extraoral swelling in the surgical zone), and 4 = severe (extraoral swelling extending beyond the surgical zone and visible hematoma and ecchymosis). |
1, 3 and 7 days
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Changes in Bone Density and Vertical Bone Height Assessed by Cone-Beam Computed Tomography (CBCT)
大体时间:Immediately and 6 months post-operatively
|
Assessment of bone regeneration promoted by the oxygen-releasing oral gel. Vertical bone height will be measured in millimeters (mm) and bone density will be evaluated using CBCT scans immediately and 6 months post-operatively. |
Immediately and 6 months post-operatively
|
|
Histomorphometric Analysis of Bone Quality Using H&E and Masson's Trichrome Staining
大体时间:6 months post-operatively
|
Assessment of bone quality evaluated by histomorphometric analysis of tissue sections stained with Hematoxylin and Eosin (H&E) and Masson's Trichrome. The measurement quantifies the distribution and number of osteoblasts and osteocytes, as well as the maturation of bone (differentiating between woven and lamellar bone) at 6 months post-operatively. Higher maturation of lamellar bone and balanced cellular distribution indicate better outcomes. |
6 months post-operatively
|
合作者和调查者
出版物和有用的链接
一般刊物
- Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: a review of the literature. Dermatol Surg. 2008 Sep;34(9):1159-69. doi: 10.1111/j.1524-4725.2008.34254.x. Epub 2008 May 29.
- Alshehri, F.A., 2023. Role of Topical Oxygen Oral Therapy in Wound Healing of Oral and Periodontal Tissues: A Narrative Review. Pakistan Oral & Dental Journal, 43(3), pp.106-113.
- Lindholm C, Searle R. Wound management for the 21st century: combining effectiveness and efficiency. Int Wound J. 2016 Jul;13 Suppl 2(Suppl 2):5-15. doi: 10.1111/iwj.12623.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
关键字
其他研究编号
- 2025/1005
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.